Conditions
A chronic lung condition causing airway inflammation, wheezing, breathlessness, chest tightness, and coughing. Affects 1 in 9 Australians.
Symptoms can overlap across conditions. A doctor considers context, red flags, and whether remote review is appropriate.
Online review can help with some straightforward situations, but it is not a substitute for urgent care, physical examination, or ongoing GP management.
Depending on your situation, an AHPRA-registered doctor may be able to issue a medical certificate or arrange a repeat prescription after reviewing your request online.
Online care is not suitable for every situation. A doctor decides what fits after assessment.
These indicators suggest you should seek professional medical advice promptly.
Seek emergency care if
Urgent: Call 000
Call 000 or go to your nearest emergency department
InstantMed Clinical Team · AHPRA-registered medical team · Reviewed 2026-03
Asthma is one of the most common chronic conditions in Australia, and it is both undertreated and over-relied upon with reliever inhalers. The critical insight most patients miss is that reliever inhalers (Ventolin/salbutamol) treat symptoms but do nothing to address the underlying airway inflammation. If you are using your reliever more than twice a week, you need a preventer. Many Australians carry a blue inhaler and nothing else - this is suboptimal management. For stable, well-characterised asthma, telehealth is well-suited for prescription renewals and management reviews because the assessment is largely history-based: how often do you use your reliever? Do you wake at night? Can you exercise? These questions tell me whether your current treatment is adequate. What telehealth cannot replace is an in-person assessment during an acute exacerbation - if you are struggling to breathe, speak in full sentences, or your reliever is not providing relief, that is a 000 situation or an emergency department, not a telehealth form.
Asthma treatment follows a stepwise approach based on symptom frequency and severity. The two main categories are preventer inhalers - inhaled corticosteroids (ICS) taken daily to reduce airway inflammation - and reliever inhalers - short-acting beta-2 agonists (SABA) used as needed for acute symptoms. For moderate-to-severe asthma, long-acting beta-2 agonist (LABA) combination inhalers are added to preventer therapy. Montelukast (a leukotriene receptor antagonist) can be added for allergic asthma or exercise-induced symptoms. For severe, difficult-to-control asthma, biologic therapies targeting specific inflammatory pathways are available through specialist referral. Most Australians with asthma over-rely on reliever inhalers and under-use preventers - if you need your reliever more than twice per week, your asthma is not well controlled.
Ventolin, Asmol. Class: Short-acting beta-2 agonist (SABA) - reliever. Typical dose: 2 puffs as needed for symptoms (max 8 puffs in 4 hours). PBS: PBS listed for reversible airway obstruction. PBS
Flixotide. Class: Inhaled corticosteroid (ICS) - preventer. Typical dose: 125-250mcg twice daily (medium dose). PBS: PBS listed for asthma prevention. PBS
Symbicort. Class: Inhaled corticosteroid + long-acting beta-agonist (ICS/LABA). Typical dose: 200/6mcg, 1-2 puffs twice daily (can also be used as reliever in SMART regimen). PBS: PBS listed for moderate-severe asthma. PBS
Singulair. Class: Leukotriene receptor antagonist. Typical dose: 10mg once daily (adults). PBS: PBS listed as add-on therapy for asthma not controlled by ICS alone. PBS
Source: Therapeutic Guidelines - Respiratory, 2024; National Asthma Council Australia Guidelines. This information is educational only and does not replace clinical assessment.
Specialist referral: Referral to a respiratory physician is recommended if asthma is not controlled despite combination ICS/LABA preventer therapy, if you have had a life-threatening asthma attack, if the diagnosis is uncertain, or for consideration of biologic therapies (mepolizumab, dupilumab) for severe eosinophilic or allergic asthma.
Typical recovery timeline and return-to-work guidance for most patients.
Asthma is a chronic condition managed rather than cured. During a flare, most people stabilise within 3-7 days with appropriate treatment. Viral-triggered exacerbations may take 2-3 weeks for full recovery.
Mild flares: most people can continue working with increased reliever use and avoiding triggers. Moderate-severe flares: 2-5 days off may be needed, particularly if oral corticosteroids are required. Avoid cold air and exercise triggers during recovery.
Seek emergency care immediately if your reliever is not providing relief, you cannot speak in full sentences, or your lips or fingers appear blue. See a doctor if you are using your reliever daily, waking at night with symptoms, or have had more than 2 exacerbations in the past 12 months.
Evidence-based tips to support your recovery alongside medical treatment.
Remote review is not suitable for every situation. A doctor reviews the information and decides whether online care is appropriate.